@article{article, title  = {{Dupilumab provides clinically meaningful responses in children aged 6–11 years with severe atopic dermatitis: post hoc analysis results from a phase III trial}},

 publisher = {{Springer Science and Business Media LLC}},

 url = {{https://eprints.whiterose.ac.uk/id/eprint/202963 }},

 year = {{2023}},

 month = {{6}},

 author = {{Siegfried EC and Cork MJ and Katoh N and Zhang H and Chuang C-C and Thomas RB and Rossi AB and Cyr SL and Zhang A}},

 doi = {{10.1007/s40257-023-00791-7}},

 volume = {{24}},

 journal = {{American Journal of Clinical Dermatology}},

 issue = {{5}},

 pages = {{787-798}},

 note = {{Accessed on 2024/12/22}}}